These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15680264)

  • 1. AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation.
    Rodella LF; Borsani E; Rezzani R; Ricci F; Buffoli B; Bianchi R
    Eur J Pharmacol; 2005 Jan; 508(1-3):139-46. PubMed ID: 15680264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain.
    Borsani E; Labanca M; Bianchi R; Rodella LF
    Brain Res; 2007 Jun; 1152():87-94. PubMed ID: 17459353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model.
    Haranishi Y; Hara K; Terada T
    Pharmacol Rep; 2021 Jun; 73(3):820-827. PubMed ID: 33783763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
    Lam FF; Luk PW; Ng ES
    Life Sci; 2007 Mar; 80(16):1495-502. PubMed ID: 17275857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
    Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
    Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models.
    Mitchell VA; Greenwood R; Jayamanne A; Vaughan CW
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1186-90. PubMed ID: 17880375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors.
    Kelley BG; Thayer SA
    Eur J Pharmacol; 2004 Aug; 496(1-3):33-9. PubMed ID: 15288572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain.
    Costa B; Siniscalco D; Trovato AE; Comelli F; Sotgiu ML; Colleoni M; Maione S; Rossi F; Giagnoni G
    Br J Pharmacol; 2006 Aug; 148(7):1022-32. PubMed ID: 16770320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anandamide transport inhibitor AM404 reduces ethanol self-administration.
    Cippitelli A; Bilbao A; Gorriti MA; Navarro M; Massi M; Piomelli D; Ciccocioppo R; Rodríguez de Fonseca F
    Eur J Neurosci; 2007 Jul; 26(2):476-86. PubMed ID: 17650118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors.
    Farquhar-Smith WP; Jaggar SI; Rice AS
    Pain; 2002 May; 97(1-2):11-21. PubMed ID: 12031775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats.
    del Carmen García M; Adler-Graschinsky E; Celuch SM
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):270-6. PubMed ID: 14504685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system.
    Palazzo E; de Novellis V; Petrosino S; Marabese I; Vita D; Giordano C; Di Marzo V; Mangoni GS; Rossi F; Maione S
    Eur J Neurosci; 2006 Oct; 24(7):2011-20. PubMed ID: 17040473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E; Martín MI; López-Miranda V
    Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
    White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
    Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anandamide transport inhibitor AM404 activates vanilloid receptors.
    Zygmunt PM; Chuang H; Movahed P; Julius D; Högestätt ED
    Eur J Pharmacol; 2000 May; 396(1):39-42. PubMed ID: 10822052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid activation of recombinant and endogenous vanilloid receptors.
    Ralevic V; Kendall DA; Jerman JC; Middlemiss DN; Smart D
    Eur J Pharmacol; 2001 Jul; 424(3):211-9. PubMed ID: 11672565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys.
    Schindler CW; Scherma M; Redhi GH; Vadivel SK; Makriyannis A; Goldberg SR; Justinova Z
    Psychopharmacology (Berl); 2016 May; 233(10):1867-77. PubMed ID: 26803499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
    Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
    Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
    Haller VL; Cichewicz DL; Welch SP
    Eur J Pharmacol; 2006 Sep; 546(1-3):60-8. PubMed ID: 16919265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.